$24.83
0.180.73%
At Close: -
$24.83
00.00%
After Hours: Jul 19, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Alkermes
ALKSNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Alkermes (NASDAQ:ALKS) Stock, Analyst Ratings, Price Targets, Forecasts
Alkermes PLC has a consensus price target of $34.38 based on the ratings of 17 analysts. The high is $50 issued by Jefferies on April 9, 2024. The low is $25 issued by UBS on February 20, 2024. The 3 most-recent analyst ratings were released by JP Morgan, TD Cowen, and HC Wainwright & Co. on July 15, 2024, June 17, 2024, and June 4, 2024, respectively. With an average price target of $33.33 between JP Morgan, TD Cowen, and HC Wainwright & Co., there's an implied 34.25% upside for Alkermes PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
TD Cowen
HC Wainwright & Co.
Cantor Fitzgerald
Jefferies
1calculated from analyst ratings
Analyst Ratings for Alkermes
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/15/2024 | Buy Now | 24.85% | JP Morgan | Jessica Fye | $32 → $31 | Maintains | Neutral | Get Alert |
| 06/17/2024 | Buy Now | 36.93% | TD Cowen | Joseph Thome | → $34 | Initiates | → Buy | Get Alert |
| 06/04/2024 | Buy Now | 40.96% | HC Wainwright & Co. | Douglas Tsao | $35 → $35 | Reiterates | Neutral → Neutral | Get Alert |
| 05/23/2024 | Buy Now | 93.31% | Cantor Fitzgerald | Charles Duncan | $43 → $48 | Maintains | Overweight | Get Alert |
| 05/02/2024 | Buy Now | 40.96% | HC Wainwright & Co. | Douglas Tsao | → $35 | Reiterates | Neutral → Neutral | Get Alert |
| 04/19/2024 | Buy Now | 40.96% | HC Wainwright & Co. | Douglas Tsao | → $35 | Reiterates | Neutral → Neutral | Get Alert |
| 04/09/2024 | Buy Now | 101.37% | Jefferies | Akash Tewari | $42 → $50 | Maintains | Buy | Get Alert |
| 04/01/2024 | Buy Now | 57.07% | Piper Sandler | David Amsellem | $39 → $39 | Reiterates | Overweight → Overweight | Get Alert |
| 03/19/2024 | Buy Now | 49.01% | Baird | Joel Beatty | → $37 | Initiates | → Outperform | Get Alert |
| 02/20/2024 | Buy Now | 0.68% | UBS | Ashwani Verma | $25 → $25 | Downgrade | Neutral → Sell | Get Alert |
| 02/16/2024 | Buy Now | 57.07% | Piper Sandler | David Amsellem | $35 → $39 | Maintains | Overweight | Get Alert |
| 01/02/2024 | Buy Now | 16.79% | B of A Securities | Jason Gerberry | $27 → $29 | Maintains | Neutral | Get Alert |
| 11/20/2023 | Buy Now | 32.9% | JP Morgan | Jessica Fye | → $33 | Reinstates | → Neutral | Get Alert |
| 10/27/2023 | Buy Now | 40.96% | Piper Sandler | David Amsellem | $37 → $35 | Maintains | Overweight | Get Alert |
| 10/26/2023 | Buy Now | 40.96% | Mizuho | Uy Ear | $37 → $35 | Maintains | Buy | Get Alert |
| 10/24/2023 | Buy Now | — | Evercore ISI Group | Umer Raffat | — | Upgrade | In-Line → Outperform | Get Alert |
| 10/17/2023 | Buy Now | 24.85% | UBS | Ashwani Verma | → $31 | Initiates | → Neutral | Get Alert |
| 07/27/2023 | Buy Now | 36.93% | HC Wainwright & Co. | Douglas Tsao | → $34 | Reiterates | Neutral → Neutral | Get Alert |
| 06/07/2023 | Buy Now | 49.01% | Piper Sandler | David Amsellem | $35 → $37 | Maintains | Overweight | Get Alert |
| 06/06/2023 | Buy Now | 32.9% | Stifel | Paul Matteis | $31 → $33 | Maintains | Hold | Get Alert |
| 04/27/2023 | Buy Now | 44.99% | Mizuho | Uy Ear | $37 → $36 | Maintains | Buy | Get Alert |
| 04/27/2023 | Buy Now | 36.93% | HC Wainwright & Co. | Douglas Tsao | $32 → $34 | Maintains | Neutral | Get Alert |
| 04/25/2023 | Buy Now | 24.85% | JP Morgan | Jessica Fye | $29 → $31 | Maintains | Neutral | Get Alert |
| 04/11/2023 | Buy Now | 49.01% | Mizuho | Uy Ear | $36 → $37 | Maintains | Buy | Get Alert |
| 02/17/2023 | Buy Now | 28.88% | HC Wainwright & Co. | Douglas Tsao | → $32 | Reiterates | → Neutral | Get Alert |
| 12/06/2022 | Buy Now | 16.79% | JP Morgan | Jessica Fye | $33 → $29 | Maintains | Neutral | Get Alert |
| 11/22/2022 | Buy Now | 44.99% | Mizuho | Uy Ear | $34 → $36 | Maintains | Buy | Get Alert |
| 11/03/2022 | Buy Now | 20.82% | Piper Sandler | David Amsellem | $26 → $30 | Upgrade | Neutral → Overweight | Get Alert |
| 10/14/2022 | Buy Now | 0.68% | B of A Securities | Jason Gerberry | $27 → $25 | Upgrade | Underperform → Neutral | Get Alert |
| 08/16/2022 | Buy Now | 4.71% | Piper Sandler | David Amsellem | → $26 | Initiates | → Neutral | Get Alert |
| 07/28/2022 | Buy Now | 36.93% | Mizuho | Vamil Divan | $36 → $34 | Maintains | Buy | Get Alert |
| 04/28/2022 | Buy Now | 8.74% | SVB Leerink | Marc Goodman | $24 → $27 | Maintains | Market Perform | Get Alert |
| 04/28/2022 | Buy Now | 28.88% | HC Wainwright & Co. | Douglas Tsao | $30 → $32 | Maintains | Neutral | Get Alert |
| 04/21/2022 | Buy Now | 0.68% | SVB Leerink | Marc Goodman | $24 → $25 | Maintains | Market Perform | Get Alert |
| 04/20/2022 | Buy Now | 40.96% | Goldman Sachs | Chris Shibutani | → $35 | Initiates | → Buy | Get Alert |
| 03/22/2022 | Buy Now | 4.71% | Citigroup | Navann Ty | $22 → $26 | Maintains | Neutral | Get Alert |
| 01/27/2022 | Buy Now | 28.88% | Cantor Fitzgerald | Brandon Folkes | $28 → $32 | Upgrade | Neutral → Overweight | Get Alert |
| 12/01/2021 | Buy Now | -11.4% | Citigroup | Navann Ty | — | Initiates | → Neutral | Get Alert |
| 11/09/2021 | Buy Now | -3.34% | SVB Leerink | Marc Goodman | — | Maintains | Market Perform | Get Alert |
| 10/28/2021 | Buy Now | 20.82% | HC Wainwright & Co. | Douglas Tsao | — | Maintains | Neutral | Get Alert |
| 10/07/2021 | Buy Now | 44.99% | Jefferies | Akash Tewari | — | Upgrade | Hold → Buy | Get Alert |
| 09/02/2021 | Buy Now | 8.74% | B of A Securities | Jason Gerberry | — | Downgrade | Neutral → Underperform | Get Alert |
| 07/29/2021 | Buy Now | 32.9% | Mizuho | Vamil Divan | — | Maintains | Buy | Get Alert |
| 07/29/2021 | Buy Now | 0.68% | SVB Leerink | Marc Goodman | — | Maintains | Market Perform | Get Alert |
FAQ
What is the target price for Alkermes (ALKS) stock?
The latest price target for Alkermes (NASDAQ:ALKS) was reported by JP Morgan on July 15, 2024. The analyst firm set a price target for $31.00 expecting ALKS to rise to within 12 months (a possible 24.85% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alkermes (ALKS)?
The latest analyst rating for Alkermes (NASDAQ:ALKS) was provided by JP Morgan, and Alkermes maintained their neutral rating.
When was the last upgrade for Alkermes (ALKS)?
The last upgrade for Alkermes PLC happened on October 24, 2023 when Evercore ISI Group raised their price target to N/A. Evercore ISI Group previously had an in-line for Alkermes PLC.
When was the last downgrade for Alkermes (ALKS)?
The last downgrade for Alkermes PLC happened on February 20, 2024 when UBS changed their price target from $25 to $25 for Alkermes PLC.
When is the next analyst rating going to be posted or updated for Alkermes (ALKS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alkermes, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alkermes was filed on July 15, 2024 so you should expect the next rating to be made available sometime around July 15, 2025.
Is the Analyst Rating Alkermes (ALKS) correct?
While ratings are subjective and will change, the latest Alkermes (ALKS) rating was a maintained with a price target of $32.00 to $31.00. The current price Alkermes (ALKS) is trading at is $24.83, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.